Wellington Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Wellington Management Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.14B	Sell	4,813,386 -641,362	-12%	-$286M	0.39%	61
2025 Q1	$2.64B	Sell	5,454,748 -461,336	-8%	-$224M	0.51%	44
2024 Q4	$2.38B	Buy	5,916,084 +1,117,214	+23%	+$450M	0.44%	53
2024 Q3	$2.23B	Buy	4,798,870 +704,421	+17%	+$328M	0.39%	62
2024 Q2	$1.92B	Sell	4,094,449 -463,784	-10%	-$217M	0.34%	66
2024 Q1	$1.91B	Sell	4,558,233 -670,305	-13%	-$280M	0.34%	70
2023 Q4	$2.13B	Sell	5,228,538 -1,297,313	-20%	-$528M	0.4%	58
2023 Q3	$2.27B	Sell	6,525,851 -1,027,043	-14%	-$357M	0.45%	49
2023 Q2	$2.66B	Buy	7,552,894 +35,346	+0.5%	+$12.4M	0.5%	43
2023 Q1	$2.37B	Buy	7,517,548 +689,965	+10%	+$217M	0.47%	51
2022 Q4	$1.97B	Sell	6,827,583 -1,201,759	-15%	-$347M	0.4%	60
2022 Q3	$2.32B	Sell	8,029,342 -206,297	-3%	-$59.7M	0.5%	50
2022 Q2	$2.32B	Buy	8,235,639 +181,929	+2%	+$51.3M	0.47%	57
2022 Q1	$2.1B	Buy	8,053,710 +1,535,255	+24%	+$401M	0.36%	71
2021 Q4	$1.43B	Buy	6,518,455 +427,366	+7%	+$93.8M	0.23%	105
2021 Q3	$1.1B	Sell	6,091,089 -2,204,600	-27%	-$400M	0.19%	121
2021 Q2	$1.67B	Buy	8,295,689 +209,325	+3%	+$42.2M	0.28%	90
2021 Q1	$1.74B	Sell	8,086,364 -1,120,147	-12%	-$241M	0.31%	82
2020 Q4	$2.18B	Buy	9,206,511 +3,020,047	+49%	+$714M	0.4%	64
2020 Q3	$1.68B	Sell	6,186,464 -275,346	-4%	-$74.9M	0.35%	74
2020 Q2	$1.88B	Sell	6,461,810 -1,149,958	-15%	-$334M	0.42%	61
2020 Q1	$1.81B	Buy	7,611,768 +175,609	+2%	+$41.8M	0.48%	54
2019 Q4	$1.63B	Sell	7,436,159 -807,388	-10%	-$177M	0.34%	66
2019 Q3	$1.4B	Sell	8,243,547 -15,065	-0.2%	-$2.55M	0.31%	76
2019 Q2	$1.51B	Sell	8,258,612 -570,173	-6%	-$105M	0.34%	72
2019 Q1	$1.62B	Buy	8,828,785 +210,383	+2%	+$38.7M	0.37%	63
2018 Q4	$1.43B	Sell	8,618,402 -887,386	-9%	-$147M	0.36%	68
2018 Q3	$1.83B	Sell	9,505,788 -802,611	-8%	-$155M	0.39%	62
2018 Q2	$1.75B	Sell	10,308,399 -767,106	-7%	-$130M	0.39%	63
2018 Q1	$1.81B	Sell	11,075,505 -1,308,689	-11%	-$213M	0.41%	65
2017 Q4	$1.86B	Sell	12,384,194 -883,152	-7%	-$132M	0.41%	63
2017 Q3	$2.02B	Sell	13,267,346 -2,600,854	-16%	-$395M	0.46%	54
2017 Q2	$2.04B	Sell	15,868,200 -1,897,733	-11%	-$245M	0.48%	52
2017 Q1	$1.94B	Buy	17,765,933 +2,845,775	+19%	+$311M	0.47%	51
2016 Q4	$1.1B	Buy	14,920,158 +496,319	+3%	+$36.6M	0.28%	93
2016 Q3	$1.26B	Buy	14,423,839 +336,192	+2%	+$29.3M	0.32%	77
2016 Q2	$1.21B	Sell	14,087,647 -639,526	-4%	-$55M	0.31%	75
2016 Q1	$1.17B	Sell	14,727,173 -136,813	-0.9%	-$10.9M	0.31%	81
2015 Q4	$1.87B	Buy	14,863,986 +1,405,220	+10%	+$177M	0.49%	49
2015 Q3	$1.4B	Sell	13,458,766 -416,455	-3%	-$43.4M	0.39%	62
2015 Q2	$1.71B	Sell	13,875,221 -1,483,538	-10%	-$183M	0.44%	53
2015 Q1	$1.81B	Sell	15,358,759 -1,835,273	-11%	-$217M	0.47%	46
2014 Q4	$2.04B	Sell	17,194,032 -2,664,428	-13%	-$317M	0.54%	39
2014 Q3	$2.23B	Buy	19,858,460 +3,397,356	+21%	+$382M	0.61%	30
2014 Q2	$1.56B	Buy	16,461,104 +178,644	+1%	+$16.9M	0.42%	58
2014 Q1	$1.15B	Sell	16,282,460 -259,526	-2%	-$18.4M	0.32%	74
2013 Q4	$1.23B	Buy	16,541,986 +4,439,553	+37%	+$330M	0.35%	67
2013 Q3	$918M	Sell	12,102,433 -1,241,549	-9%	-$94.1M	0.29%	76
2013 Q2	$1.07B	Buy	+13,343,982	New	+$1.07B	0.35%	66